MediciNova, Inc. (MNOV)
1.52
-0.02
(-1.30%)
USD |
NASDAQ |
Oct 09, 16:00
1.53
+0.01
(+0.66%)
After-Hours: 20:00
MediciNova Cash from Operations (Quarterly) : -1.92M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.92M |
| March 31, 2026 | -3.470M |
| December 31, 2025 | -2.017M |
| September 30, 2025 | -1.703M |
| June 30, 2025 | -2.306M |
| March 31, 2025 | -3.784M |
| December 31, 2024 | -1.932M |
| September 30, 2024 | -2.032M |
| June 30, 2024 | -2.811M |
| March 31, 2024 | -3.868M |
| December 31, 2023 | -0.4991M |
| September 30, 2023 | -1.372M |
| June 30, 2023 | -2.383M |
| March 31, 2023 | -3.177M |
| December 31, 2022 | -4.007M |
| September 30, 2022 | -2.720M |
| June 30, 2022 | -2.456M |
| March 31, 2022 | -3.728M |
| December 31, 2021 | -3.639M |
| September 30, 2021 | -3.016M |
| June 30, 2021 | 1.127M |
| March 31, 2021 | -3.854M |
| December 31, 2020 | -1.949M |
| September 30, 2020 | -3.908M |
| June 30, 2020 | -2.091M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.879M |
| December 31, 2019 | -2.404M |
| September 30, 2019 | -2.039M |
| June 30, 2019 | -1.652M |
| March 31, 2019 | -3.029M |
| December 31, 2018 | -1.644M |
| September 30, 2018 | -1.736M |
| June 30, 2018 | -1.653M |
| March 31, 2018 | -4.081M |
| December 31, 2017 | -1.046M |
| September 30, 2017 | -1.919M |
| June 30, 2017 | -1.411M |
| March 31, 2017 | -2.547M |
| December 31, 2016 | -1.059M |
| September 30, 2016 | -1.582M |
| June 30, 2016 | -1.486M |
| March 31, 2016 | -2.419M |
| December 31, 2015 | -1.517M |
| September 30, 2015 | -1.170M |
| June 30, 2015 | -1.233M |
| March 31, 2015 | -3.234M |
| December 31, 2014 | -1.033M |
| September 30, 2014 | -1.591M |
| June 30, 2014 | -1.328M |
| March 31, 2014 | 4.768M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Viking Therapeutics, Inc. | -125.17M |
| IDEAYA Biosciences, Inc. | -88.21M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -9.124M |
| Free Cash Flow Per Share (Quarterly) | -0.039 |
| Free Cash Flow to Equity (Quarterly) | -1.872M |
| Free Cash Flow to Firm (Quarterly) | -1.92M |
| Free Cash Flow Yield | -12.21% |